ET
TARS icon

Entropy Technologies’s Tarsus Pharmaceuticals TARS Stock Holding History

Entropy Technologies’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55M Buy
+24,583
New +$1.57M 0.06% 395
2026
Q1 		– Sell
-9,396
Closed -$769K – 1153
2025
Q4 		$769K Buy
+9,396
New +$702K 0.04% 449

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Entropy Technologies's TARS Position: Q2 2026 in Review

Entropy Technologies opened a new position in Tarsus Pharmaceuticals (TARS) in Q2 2026: 24,583 shares worth $1.55M. The stake represents 0.06% of the portfolio and ranks #395 among its holdings. This is a return to the name: Entropy Technologies previously reported a position in TARS as recently as Q4 2025.

Entropy Technologies first reported a position in TARS in Q4 2025 and has held it in 2 quarters since. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Entropy Technologies held 24,583 shares of Tarsus Pharmaceuticals worth $1.55M as of Q2 2026.
  • Tarsus Pharmaceuticals was a new Entropy Technologies position in Q2 2026.
  • Tarsus Pharmaceuticals made up 0.06% of Entropy Technologies's portfolio in Q2 2026, its #395 holding.
  • Entropy Technologies first reported a position in Tarsus Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.